For Publishers
DiscoveryMetadataPeer reviewHostingPublishing
For Researchers
JoinPublishReviewCollect
Register
Blog
About
Search
Advanced search
My ScienceOpen
Search
For Publishers
For Researchers
Blog
About
2
views
0
references
 Top references
cited by
12
    
0 reviews
 Review
0
comments
 Comment
0
recommends
+1 Recommend
0 collections
    0
    shares
      0
      similar
       All similar
      • Record: found
      • Abstract: found
      • Article: not found

      Androgen Receptor Splice Variant 7 Predicts Shorter Response in Patients with Metastatic Hormone-sensitive Prostate Cancer Receiving Androgen Deprivation Therapy.

      Read this article at

      ScienceOpenPublisherPubMed
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Whether AR-V7 expression can predict the response in patients with metastatic hormone-sensitive prostate cancer (mHSPC) who receive androgen deprivation therapy (ADT) remains to be explored.

          Related collections

          Author and article information

          Journal
          Journal ID (iso-abbrev): Eur Urol
          Title: European urology
          Publisher: Elsevier BV
          ISSN (Electronic): 1873-7560
          ISSN (Print): 0302-2838
          Publication date (Electronic): June 2021
          Volume: 79
          Issue: 6
          Affiliations
          [1 ] Department of Urology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China; Institute of Urology of Hubei Province, Wuhan, China.
          [2 ] Department of Geriatrics, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
          [3 ] Department of Urology, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.
          [4 ] Department of Urology, Chinese PLA General Hospital, Beijing, China.
          [5 ] Department of Urology, Zhujiang Hospital of Southern Medical University, Guangzhou, China.
          [6 ] Department of Urology, the First Affiliated Hospital of Harbin Medical University, Harbin, China.
          [7 ] Department of Urology, the First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China.
          [8 ] Department of Urology, the First Affiliated Hospital of Nanchang University, Nanchang, China.
          [9 ] Department of Pathology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
          [10 ] Department of Pathology, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.
          [11 ] Department of Pathology, Zhujiang Hospital of Southern Medical University, Guangzhou, China.
          [12 ] Department of Pathology, the First Affiliated Hospital of Harbin Medical University, Harbin, China.
          [13 ] Department of Pathology, Chinese PLA General Hospital, Beijing, China.
          [14 ] Department of Urology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China; Institute of Urology of Hubei Province, Wuhan, China. Electronic address: xuhuawhu@163.com.
          Article
          Publisher Item ID: S0302-2838(21)00078-6
          DOI: 10.1016/j.eururo.2021.01.037
          PubMed ID: 33579577
          SO-VID: 66effce9-9f60-4034-8972-ca8f104011aa
          History

          Keywords: Androgen deprivation therapy,Metastatic hormone-sensitive prostate cancer,Prospective cohort study,Androgen receptor splice variant 7,Immunohistochemical staining
          Data availability:
          Keywords: Androgen deprivation therapy, Metastatic hormone-sensitive prostate cancer, Prospective cohort study, Androgen receptor splice variant 7, Immunohistochemical staining

          Comments

          Comment on this article